Micropos Medical AB (publ) Revenue and Competitors
Estimated Revenue & Valuation
- Micropos Medical AB (publ)'s estimated annual revenue is currently $5M per year.
- Micropos Medical AB (publ)'s estimated revenue per employee is $251,000
Employee Data
- Micropos Medical AB (publ) has 20 Employees.
- Micropos Medical AB (publ) grew their employee count by 11% last year.
Micropos Medical AB (publ)'s People
Name | Title | Email/Phone |
---|---|---|
1 | R&D Manager | Reveal Email/Phone |
2 | Service and Installation Manager | Reveal Email/Phone |
3 | QA/RA Engineer | Reveal Email/Phone |
4 | Consultant | Reveal Email/Phone |
Micropos Medical AB (publ) Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5M | 40 | -18% | $10M | N/A |
#2 | $24.8M | 99 | 29% | N/A | N/A |
#3 | $84.1M | 0 | N/A | $1.2M | N/A |
#4 | $35.6M | 142 | 30% | N/A | N/A |
#5 | $57.5M | 229 | 6% | N/A | N/A |
#6 | $52.7M | 168 | 25% | $129.6M | N/A |
#7 | $21.1M | 84 | -3% | N/A | N/A |
#8 | $61.2M | 244 | -13% | N/A | N/A |
#9 | $60.6M | 193 | 20% | $115.5M | N/A |
#10 | $56.2M | 179 | -3% | $122.9M | N/A |
What Is Micropos Medical AB (publ)?
Micropos Medical is a Swedish medical device company with technologies for enhanced radiotherapy of cancer. The product, RayPilot® with HypoCath is an electromagnetic positioning system that works with existing linacs in order to enable non-ionizing, objective and real time prostate tracking.
keywords:N/AN/A
Total Funding
20
Number of Employees
$5M
Revenue (est)
11%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Micropos Medical AB (publ) News
2022-03-22 - Lösningen till fastighetsbranschens framtida behov av finansiering ...
VD, Tessin Nordic Holding AB (publ) +46 70 546 49 61 heidi tessin.se. Läs mer om Tessin här · Tessin. Maila: Redaktionen.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.9M | 20 | 0% | N/A |
#2 | $4.5M | 20 | -23% | N/A |
#3 | $2.9M | 20 | -20% | N/A |
#4 | $3.5M | 20 | 5% | N/A |
#5 | $2M | 20 | N/A | N/A |